TIL Desk/Business/New Delhi/ Moderna Inc is “actively” preparing to launch its potential coronavirus vaccine mRNA-1273. Meanwhile, Johnson & Johnson is planning to start testing its experimental Covid-19 vaccine among those aged 12 to 18 as soon as possible. Also, India announced on Friday that it will help all countries with vaccine and storage capacity.
Moderna CEO Stephane Bancel has said in a press release that the pharmaceutical company is preparing to launch its potential coronavirus vaccine mRNA-1273. “We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world,” Moderna CEO Stephane Bancel was quoted by reports.
Last week, Moderna had completed enrollment for its 30,000-participant late-stage trial. Till then, more than 25,650 participants had received the second of the company’s two-dose Covid-19 vaccine. A report said Moderna as saying that about 37 per cent of the participants were from diverse communities and 42 per cent were at high risk of severe disease.

कोयंबटूर में 77वें स्वतंत्रता दिवस 11 मीटर ऊंचा स्टील टावर पर घुमावदार एलईडी स्क्रीन
Elvish Yadav wins Bigg Boss OTT season 2, fans erupt in joy
Glimpses from 77th Independence Day at Red Fort in Delhi
सीएम योगी ने 77वें स्वतंत्र दिवस पर किया ध्वजारोहण
Happy 77th Independence Day
President raises climate change concerns in I-Day eve speech
Next year, on August 15 from Red Fort: PM Modi’s big remark on 2024
‘Bharat Mata is voice of every Indian’: Rahul extends wish on Independence Day
“Selfishness of few pushed nation to tragedy of Partition”: CM Yogi Adityanath